- Home
- CRVO vs ICCM Comparison
CRVO vs ICCM Comparison
Compare CRVO & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- ICCM
- Stock Information
- Founded
- CRVO 2001
- ICCM 2006
- Country
- CRVO United States
- ICCM Israel
- Employees
- CRVO N/A
- ICCM N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- ICCM
- Sector
- CRVO Health Care
- ICCM
- Exchange
- CRVO Nasdaq
- ICCM Nasdaq
- Market Cap
- CRVO 69.3M
- ICCM 61.0M
- IPO Year
- CRVO N/A
- ICCM N/A
- Fundamental
- Price
- CRVO $8.16
- ICCM $1.05
- Analyst Decision
- CRVO Strong Buy
- ICCM Strong Buy
- Analyst Count
- CRVO 8
- ICCM 1
- Target Price
- CRVO $25.57
- ICCM $2.50
- AVG Volume (30 Days)
- CRVO 209.3K
- ICCM 254.9K
- Earning Date
- CRVO 05-12-2025
- ICCM 05-28-2025
- Dividend Yield
- CRVO N/A
- ICCM N/A
- EPS Growth
- CRVO N/A
- ICCM N/A
- EPS
- CRVO N/A
- ICCM N/A
- Revenue
- CRVO $9,308,215.00
- ICCM $3,273,000.00
- Revenue This Year
- CRVO N/A
- ICCM $85.75
- Revenue Next Year
- CRVO N/A
- ICCM $189.92
- P/E Ratio
- CRVO N/A
- ICCM N/A
- Revenue Growth
- CRVO 15.14
- ICCM 0.34
- 52 Week Low
- CRVO $1.80
- ICCM $0.48
- 52 Week High
- CRVO $22.57
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- CRVO 46.68
- ICCM 46.97
- Support Level
- CRVO $7.01
- ICCM $0.99
- Resistance Level
- CRVO $8.59
- ICCM $1.14
- Average True Range (ATR)
- CRVO 0.55
- ICCM 0.07
- MACD
- CRVO -0.12
- ICCM 0.01
- Stochastic Oscillator
- CRVO 55.56
- ICCM 64.00
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.